Literature DB >> 1200903

Nanophthalmos with uveal effusion. A new clinical entity.

R J Brockhurst.   

Abstract

Five patients exhibited the association of nanophthalmos and uveal effusion, apparently on a familial basis. Glaucoma, occurring in the fourth to sixth decades of life, required surgical intervention that was followed by the development of secondary retinal and choroidal detachment. Recognition of this syndrome is important because: (1) surgical procedures for glaucoma should be avoided, if possible, in order to prevent the development of uveal effusion; (2) retinal detachment surgical procedures are ineffective in uveal effusion and should be avoided, and (3) choroidal elevation occurring in the uveal effusion phase may be erroneously diagnosed as an intraocular tumor and unnecessary enucleation may follow.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1200903     DOI: 10.1001/archopht.1975.01010020923001

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  21 in total

1.  Changes of scleral sulfated proteoglycans in three cases of nanophthalmos.

Authors:  Takeo Fukuchi; Hideko Sawada; Masaaki Seki; Tokuhide Oyama; Hiroyuki Cho; Haruki Abe
Journal:  Jpn J Ophthalmol       Date:  2009-03-31       Impact factor: 2.447

2.  Two cases of uveal effusion syndrome.

Authors:  Jong Hyun Lee; Jin Young Choi; Sung Soo Kim
Journal:  Korean J Ophthalmol       Date:  2006-06

3.  Challenges in the implantation of a Boston type 1 keratoprosthesis and a glaucoma drainage device in a nanophthalmic eye.

Authors:  Sirisha Senthil; Kiranmaye Turaga; Ravi Kumar; Virender S Sangwan
Journal:  BMJ Case Rep       Date:  2014-10-01

4.  Medical therapy for uveal effusion syndrome.

Authors:  B Andrijević Derk; G Benčić; V Corluka; M Zorić Geber; Z Vatavuk
Journal:  Eye (Lond)       Date:  2014-06-06       Impact factor: 3.775

5.  Immunohistochemical studies of glycosaminoglycans in nanophthalmic sclera.

Authors:  M Kawamura; S Tajima; N Azuma; H Katsura; K Akiyama
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-01       Impact factor: 3.117

6.  Fundus autofluorescence and spectral-domain optical coherence tomography findings of leopard spots in nanophthalmic uveal effusion syndrome.

Authors:  Tetsuhiko Okuda; Tomomi Higashide; Yuka Wakabayashi; Akira Nishimura; Kazuhisa Sugiyama
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03-19       Impact factor: 3.117

7.  Biochemical studies of glycosaminoglycans in nanophthalmic sclera.

Authors:  M Kawamura; S Tajima; N Azuma; H Katsura; K Akiyama
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-02       Impact factor: 3.117

8.  Abnormal sclerocytes in nanophthalmos.

Authors:  T Shiono; A Shoji; T Mutoh; M Tamai
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

9.  Membrane frizzled-related protein gene-related ophthalmological syndrome: 30-month follow-up of a sporadic case and review of genotype-phenotype correlation in the literature.

Authors:  Alberto Neri; Rosachiara Leaci; Juan C Zenteno; Cristina Casubolo; Elisabetta Delfini; Claudio Macaluso
Journal:  Mol Vis       Date:  2012-10-26       Impact factor: 2.367

10.  A case of 25 gauge vitrectomy for malignant glaucoma with microphthalmos.

Authors:  Masami Nakajima; Yusuke Hara; Yoshio Yamazaki
Journal:  Clin Ophthalmol       Date:  2013-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.